Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: PF-04965842 200 mg; Drug: PF-04965842 100 mg; Drug: Placebo Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials